Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq made new all-time highs for a sec-
ond straight week, continuing to hold trend above their respective 21-DMA (S&P 500: 3,718; Nasdaq: 12,732).

The distribution day count stands at four each, with one day expiring on each index next week.

Hansoh Pharma

Key points from this report:

 

  • Buy Hansoh Pharmaceutical. The stock is building the right side of a 29-week consolidation in good volume with a pivot of HKD 40.90.
  • New drugs included in reimbursement list. On December 28, Hansoh’s three newly launched drugs were included in China’s National Drug Reimbursement List.
  • Rich pipeline. During H1, Hansoh obtained clinical approvals of 10 drugs and filed marketing applications for an additional 10 drugs.
  • Leadership position in China’s psychotropic market. Hansoh is China’s largest psychotropic pharmaceutical company in terms of revenue, with a market share of ~9%.
  • Next catalyst: The company is expected to announce 2020 results in March. Consensus expects 16% y/y revenue growth and 9% y/y EPS growth in 2020. Consensus expects 25%+ revenue and earnings growth in 2021.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq closed the year at all-time highs
and above all major moving averages with limited distribution. Near-term support remains the rising 10- and
21-DMA (S&P 500: 3,689; Nasdaq: 12,612). The distribution day count stands at four and two, respectively,
with one day expiring on the S&P 500 next week.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq continue to display constructive
technical action, trading at or near all-time highs and above all major moving averages with limited distribution.
Support remains the rising 10- and 21-DMA (S&P 500: 3,668; Nasdaq: 12,492). The distribution day count
stands at five and two, respectively, with one day expiring on the S&P 500 next week.

Market View

The U.S. market remains in a Confirmed Uptrend. The S&P 500 and Nasdaq made new all-time highs this

week, continuing to trend higher off 10- and 21-DMA (S&P 500: 3,652; Nasdaq: 12,351) support. The distribu-
tion day count is mixed at six and two, respectively, though both have avoided clustering into further expiration

next week.